CHIESI Company Profile

✉ Email this page to a colleague

CHIESI has fifteen approved drugs.

There are forty-eight US patents protecting CHIESI drugs.

There are three hundred and four patent family members on CHIESI drugs in forty-one countries and fifty-three supplementary protection certificates in eighteen countries.

International Patents:	304
US Patents:	48
Tradenames:	16
Ingredients:	10
NDAs:	15
Patent Litigation for CHIESI:	See patent lawsuits for CHIESI

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-004	Apr 23, 2015		RX	Yes	No	9,433,617	⤷ Try a Trial				⤷ Try a Trial
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-001	Dec 21, 2012		RX	Yes	No	7,932,268	⤷ Try a Trial				⤷ Try a Trial
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-001	Dec 21, 2012		RX	Yes	No	8,618,135	⤷ Try a Trial				⤷ Try a Trial
Chiesi	CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	019734-003	Jul 31, 2008		RX	Yes	Yes	7,659,291	⤷ Try a Trial				⤷ Try a Trial
Chiesi	CARDENE SR	nicardipine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020005-001	Feb 21, 1992		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Chiesi	KENGREAL	cangrelor	POWDER;INTRAVENOUS	204958-001	Jun 22, 2015		RX	Yes	Yes	10,039,780	⤷ Try a Trial				⤷ Try a Trial
Chiesi	KENGREAL	cangrelor	POWDER;INTRAVENOUS	204958-001	Jun 22, 2015		RX	Yes	Yes	9,295,687	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-001	Dec 21, 2012	5,739,135	⤷ Try a Trial
Chiesi	CARDENE	nicardipine hydrochloride	CAPSULE;ORAL	019488-001	Dec 21, 1988	3,985,758	⤷ Try a Trial
Chiesi	CLEVIPREX	clevidipine	EMULSION;INTRAVENOUS	022156-002	Aug 1, 2008	5,856,346	⤷ Try a Trial
Chiesi	CARDENE SR	nicardipine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020005-002	Feb 21, 1992	3,985,758	⤷ Try a Trial
Chiesi	FERRIPROX	deferiprone	SOLUTION;ORAL	208030-002	Apr 20, 2018	7,049,328	⤷ Try a Trial
Chiesi	BETHKIS	tobramycin	SOLUTION;INHALATION	201820-001	Oct 12, 2012	6,987,094	⤷ Try a Trial
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-003	Dec 21, 2012	5,712,279	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	0.1 mg/mL, 200 mL and0.2mg/mL, 200 mL	➤ Subscribe	2013-06-20
➤ Subscribe	Tablets	500 mg	➤ Subscribe	2016-01-29
➤ Subscribe	Injection	2.5 mg/mL, 10 mL Ampoules	➤ Subscribe	2006-12-27
➤ Subscribe	Inhalation Solution	300 mg/4 mL	➤ Subscribe	2017-08-31

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Australia	2005253732	⤷ Try a Trial
Eurasian Patent Organization	023983	⤷ Try a Trial
Japan	2012502973	⤷ Try a Trial
European Patent Office	2741610	⤷ Try a Trial
Spain	2773040	⤷ Try a Trial
Brazil	112020009867	⤷ Try a Trial
South Korea	20070046821	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1758555	2016/031	Ireland	⤷ Try a Trial	PRODUCT NAME: BETULIN (BIRCH BARK EXTRACT); REGISTRATION NO/DATE: EU/1/15/1069 20160114
1280520	14/2015	Austria	⤷ Try a Trial	PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720
1280520	92678	Luxembourg	⤷ Try a Trial	PRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725
0726894	12C0053	France	⤷ Try a Trial	PRODUCT NAME: CLEVIDIPINE; NAT. REGISTRATION NO/DATE: NL 37621 20120725; FIRST REGISTRATION: GB - PL 16881/0003 20111123
1758555	93142	Luxembourg	⤷ Try a Trial	PRODUCT NAME: BETULINE (EXTRAIT D'ECORCE DE BOULEAU) - EPISALVAN; FIRST REGISTRATION DATE: 20160118
0748228	SPC/GB11/004	United Kingdom	⤷ Try a Trial	PRODUCT NAME: MANNITOL; REGISTERED: SE 22708 20061020; UK PL 27944/0001-0001 20071218
1280520	C01280520/01	Switzerland	⤷ Try a Trial	PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.